Home 9 All Videos 9 Anticoagulant Reversal Strategies in ICH – Current challenges and latest insights

Anticoagulant Reversal Strategies in ICH – Current challenges and latest insights

May 21, 2024

This interview discusses anticoagulant reversal strategies in ICH and the current challenges and latest insights. The interview was conducted during ESOC 2024 at the ESOC studios, featuring  Professor Thorsten Steiner & Dr David Seiffge

This discussion is supported by an unrestricted medical education grant from AstraZeneca

 

Learning objectives from this video:

  • Recognise the risk factors for intracerebral haemorrhage (ICH), particularly in patients prescribed oral anticoagulation, including the importance of timely diagnosis for effective haemostasis.
  • State the challenges from the 2019 guidelines and discuss the remaining clinical unmet needs.
  • Recall the guidelines on managing ICH in patients with prescribed oral anticoagulants.
  • Discuss recent trials exploring reversal of FXa-inhibitors for efficacy and safety.

 

0 Comments

Newsletter

Keep up to date with our latest
articles and journals